EVIDENCE FOR ENERGY-DEPENDENT TRANSPORT OF ALUMINUM OUT OF BRAIN EXTRACELLULAR FLUID

被引:26
作者
ALLEN, DD
ORVIG, C
YOKEL, RA
机构
[1] UNIV KENTUCKY,MED CTR,COLL MED,LEXINGTON,KY 40536
[2] UNIV BRITISH COLUMBIA,DEPT CHEM,VANCOUVER,BC V6T 1Z1,CANADA
[3] UNIV KENTUCKY,GRAD CTR TOXICOL,LEXINGTON,KY 40536
关键词
ALUMINUM; ENERGY-DEPENDENT ACTIVE TRANSPORT; BLOOD-BRAIN BARRIER; MICRODIALYSIS;
D O I
10.1016/0300-483X(94)02953-R
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aluminum (Al) can cause CNS toxicity. The mechanism of its blood-brain barrier (BBB) permeation is poorly understood. In this study, microdialysis was used to determine extracellular fluid (ECF) unbound aluminum distribution between frontal cortex (FC) and blood during steady-state aluminum concentrations. The brain/blood aluminum ratio was determined. Over a 16-fold range of aluminum concentrations (dosed as aluminum citrate), brain/blood aluminum ratios were 0.10-0.15, consistently and significantly <1. Aluminum diffusion cannot account for these results, suggesting the presence of a carrier that moves aluminum out of brain extracellular fluid. These aluminum brain/blood ratios (BBRs) were not significantly different over the range of concentrations studied, suggesting an inability to saturate the carrier. Brain/blood aluminum ratios obtained with four aluminum-hydroxypyridinones were also significantly <1 (0.1-0.3), and were generally significantly different among themselves and from the aluminum citrate BBR. Movement of a BBB permeability marker from blood into brain extracellular fluid suggested partial BBB opening. The aluminum BBRs obtained (all much less than 1), in the presence of a partially opened BBR, suggest an efficient carrier moving aluminum out of brain ECF. Addition of cyanide to the brain microdialysis probe solution significantly increased the Al (citrate) BBR to 1, These results suggest the presence of an efficient, energy-dependent carrier that removes aluminum from brain ECF, either into brain cells or blood.
引用
收藏
页码:31 / 39
页数:9
相关论文
共 36 条
[1]   METABOLISM AND TOXICITY OF ALUMINUM IN RENAL-FAILURE [J].
ALFREY, AC ;
HEGG, A ;
CRASWELL, P .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1980, 33 (07) :1509-1516
[2]   4-TRIMETHYLAMMONIUM ANTIPYRINE - A QUATERNARY AMMONIUM NONRADIONUCLIDE MARKER FOR BLOOD-BRAIN-BARRIER INTEGRITY DURING INVIVO MICRODIALYSIS [J].
ALLEN, DD ;
CROOKS, PA ;
YOKEL, RA .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1992, 28 (03) :129-135
[3]   PHARMACOKINETICS OF ALUMINUM 3-HYDROXYPYRIDIN-4-ONE COMPLEXES - IMPLICATIONS FOR ALUMINUM REDISTRIBUTION SUBSEQUENT TO CHELATION-THERAPY [J].
ALLEN, DD ;
ORVIG, C ;
YOKEL, RA .
TOXICOLOGY, 1994, 92 (1-3) :193-202
[4]   DISSIMILAR ALUMINUM AND GALLIUM PERMEATION OF THE BLOOD-BRAIN-BARRIER DEMONSTRATED BY INVIVO MICRODIALYSIS [J].
ALLEN, DD ;
YOKEL, RA .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (03) :903-908
[5]   ALUMINUM ALTERS THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER TO SOME NON-PEPTIDES [J].
BANKS, WA ;
KASTIN, AJ .
NEUROPHARMACOLOGY, 1985, 24 (05) :407-412
[6]   A LONG-TERM INTRAVENOUS MODEL OF ALUMINUM MALTOL TOXICITY IN RABBITS - TISSUE DISTRIBUTION, HEPATIC, RENAL, AND NEURONAL CYTOSKELETAL CHANGES ASSOCIATED WITH SYSTEMIC EXPOSURE [J].
BERTHOLF, RL ;
HERMAN, MM ;
SAVORY, J ;
CARPENTER, RM ;
STURGILL, BC ;
KATSETOS, CD ;
VANDENBERG, SR ;
WILLS, MR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 98 (01) :58-74
[7]   RELEASE OF IRON FROM FERRITIN MOLECULES AND THEIR IRON-CORES BY 3-HYDROXYPYRIDINONE CHELATORS INVITRO [J].
BRADY, MC ;
LILLEY, KS ;
TREFFRY, A ;
HARRISON, PM ;
HIDER, RC ;
TAYLOR, PD .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1989, 35 (01) :9-22
[8]   TRANSPORT OF PB-203 AT THE BLOOD-BRAIN-BARRIER DURING SHORT CEREBROVASCULAR PERFUSION WITH SALINE IN THE RAT [J].
DEANE, R ;
BRADBURY, MWB .
JOURNAL OF NEUROCHEMISTRY, 1990, 54 (03) :905-914
[9]  
DYKSTRA KH, 1993, CURR SEP, V12, P86
[10]  
FOX JL, 1986, RSTRIP PHARMACOKINET